ponalrestat has been researched along with substance p in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Keen, P; Robinson, JP; Tomlinson, DR; Willars, GB | 1 |
| Belai, A; Burnstock, G; Calcutt, NA; Carrington, AL; Diemel, LT; Tomlinson, DR | 1 |
2 other study(ies) available for ponalrestat and substance p
| Article | Year |
|---|---|
Axonal transport and tissue contents of substance P in rats with long-term streptozotocin-diabetes. Effects of the aldose reductase inhibitor 'statil'.
Topics: Aldehyde Reductase; Animals; Axonal Transport; Body Weight; Diabetes Mellitus, Experimental; Ganglia, Spinal; Gastric Mucosa; Ileum; Male; Phthalazines; Pyridazines; Rats; Rats, Inbred Strains; Stomach; Substance P; Sugar Alcohol Dehydrogenases; Trigeminal Ganglion; Trigeminal Nerve | 1987 |
Enteric neuropeptides in streptozotocin-diabetic rats; effects of insulin and aldose reductase inhibition.
Topics: Aldehyde Reductase; Animals; Antibody Specificity; Axons; Calcitonin Gene-Related Peptide; Diabetes Mellitus, Experimental; Galanin; Hypoglycemic Agents; Ileum; Immunohistochemistry; Insulin; Intestines; Male; Myenteric Plexus; Neurons; Neuropeptides; Phthalazines; Rats; Rats, Wistar; Substance P; Vasoactive Intestinal Peptide | 1996 |